Literature DB >> 22357134

Mcl-1 regulates the survival of adult neural precursor cells.

Craig D Malone1, S M Mahmudul Hasan, R Brian Roome, Jieying Xiong, Michael Furlong, Joseph T Opferman, Jacqueline L Vanderluit.   

Abstract

Since the discovery of neural precursor cells (NPCs) in the adult mammalian brain, there has been a lot of excitement surrounding the potential for regeneration in the adult brain. For instance, many studies have shown that a significant number of NPCs will migrate to a site of injury and differentiate into all of the neural lineages. However, one of the main challenges affecting endogenous neural regeneration is that many of the NPCs that migrate to the injury site ultimately undergo apoptosis. Therefore, we sought to determine whether myeloid cell leukemia-1 (Mcl-1), an anti-apoptotic Bcl-2 protein, would promote the survival of adult NPCs by impeding apoptosis. To do this, we first confirmed that Mcl-1 is endogenously expressed within the adult NPC population using BrdU labeling assays. Next, we conditionally deleted Mcl-1 in adult NPCs using cre/lox technology and expressed Cre from the NPC-specific promoter Nestin. In vitro, cells that had Mcl-1 conditionally deleted had a 2-fold increase in apoptosis when compared to controls. In vivo, we used electroporation to conditionally delete Mcl-1 in adult NPCs and assessed apoptosis at 72h. after electroporation. As in our in vitro results, there was a 2-fold increase in apoptosis when Mcl-1 was conditionally deleted. Finally, we found that Mcl-1 over-expression reduced the endogenous rate of adult NPC apoptosis 2-fold in vitro. Collectively, these results demonstrate that Mcl-1 is crucial for the survival of adult NPCs and may be a promising target for future neural regeneration therapies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357134     DOI: 10.1016/j.mcn.2012.02.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  23 in total

Review 1.  Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.

Authors:  Joseph T Opferman
Journal:  FEBS J       Date:  2015-09-15       Impact factor: 5.542

Review 2.  Apoptotic cell death regulation in neurons.

Authors:  Emilie Hollville; Selena E Romero; Mohanish Deshmukh
Journal:  FEBS J       Date:  2019-07-12       Impact factor: 5.542

3.  p63 Regulates adult neural precursor and newly born neuron survival to control hippocampal-dependent Behavior.

Authors:  Gonzalo I Cancino; Adelaide P Yiu; Michael P Fatt; Chandrasagar B Dugani; Elsa R Flores; Paul W Frankland; Sheena A Josselyn; Freda D Miller; David R Kaplan
Journal:  J Neurosci       Date:  2013-07-31       Impact factor: 6.167

4.  The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy.

Authors:  H L Grabenstatter; Y Cruz Del Angel; J Carlsen; M F Wempe; A M White; M Cogswell; S J Russek; A R Brooks-Kayal
Journal:  Neurobiol Dis       Date:  2013-09-16       Impact factor: 5.996

5.  Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting.

Authors:  Anne Slomp; Laura M Moesbergen; Jia-Nan Gong; Marta Cuenca; Peter A von dem Borne; Pieter Sonneveld; David C S Huang; Monique C Minnema; Victor Peperzak
Journal:  Blood Adv       Date:  2019-12-23

6.  EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival.

Authors:  Nai Yang Fu; Anne C Rios; Bhupinder Pal; Rina Soetanto; Aaron T L Lun; Kevin Liu; Tamara Beck; Sarah A Best; François Vaillant; Philippe Bouillet; Andreas Strasser; Thomas Preiss; Gordon K Smyth; Geoffrey J Lindeman; Jane E Visvader
Journal:  Nat Cell Biol       Date:  2015-03-02       Impact factor: 28.824

Review 7.  Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy.

Authors:  Maja Sochalska; Selma Tuzlak; Alexander Egle; Andreas Villunger
Journal:  FEBS J       Date:  2015-01-23       Impact factor: 5.542

8.  A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.

Authors:  Haley E Ramsey; Melissa A Fischer; Taekyu Lee; Agnieszka E Gorska; Maria Pia Arrate; Londa Fuller; Kelli L Boyd; Stephen A Strickland; John Sensintaffar; Leah J Hogdal; Gregory D Ayers; Edward T Olejniczak; Stephen W Fesik; Michael R Savona
Journal:  Cancer Discov       Date:  2018-09-05       Impact factor: 39.397

9.  Mcl-1 and Bcl-xL are essential for survival of the developing nervous system.

Authors:  Lauren C Fogarty; Robert T Flemmer; Brittany A Geizer; Maria Licursi; Ahila Karunanithy; Joseph T Opferman; Kensuke Hirasawa; Jacqueline L Vanderluit
Journal:  Cell Death Differ       Date:  2018-10-25       Impact factor: 15.828

10.  Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction.

Authors:  Xi Wang; Madhavi Bathina; John Lynch; Brian Koss; Christopher Calabrese; Sharon Frase; John D Schuetz; Jerold E Rehg; Joseph T Opferman
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.